Document is current

Any future updates will be listed below

A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis

Crossref DOI link: https://doi.org/10.1038/s41598-024-84944-6

Published Online: 2025-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark